0% found this document useful (0 votes)
18 views1 page

SARS-CoV-2 RT-PCR Test Report

The document reports the results of a SARS CoV-2 RT PCR test for a 67-year-old male. The test was negative for SARS CoV-2. Additional information provided includes testing methodology, interpretation of results, registration details, sample type, and clinical significance of coronaviruses.

Uploaded by

rabo1285
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
18 views1 page

SARS-CoV-2 RT-PCR Test Report

The document reports the results of a SARS CoV-2 RT PCR test for a 67-year-old male. The test was negative for SARS CoV-2. Additional information provided includes testing methodology, interpretation of results, registration details, sample type, and clinical significance of coronaviruses.

Uploaded by

rabo1285
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 1

*NZB0079851* TEST REPORT

Reg.No : NZB0079851 Reg.Date : 14-May-2024 /08:29


Name : MR.GUNDLA DUBBARAJAM 713569678130 Collection : 14-May-2024 /08:30
Age\Sex : 67 Years\Male Received : 14-May-2024 /10:01
Referred By : LDSL/ADL-25 Report : 14-May-2024 /11:04
Referral Dr : SVS DIAGNOSTICS Barcode : 002107792100

SARS Cov 2 RT PCR


SARS CoV-2 RT PCR
TEST NAME OBSERVED VALUE UNITS BIOLOGICAL REF. RANGE
ORF 1ab NOT DETECTED
N gene NOT DETECTED
Interpretation : NEGATIVE FOR SARS COV 2

Method: Real Time PCR


Interpretation
Result Remarks
Positive RNA specific to SARS-CoV-2 Detected
Negative RNA specific to SARS-CoV-2 NOT detected
Inconclusive This could be due to low viral load in the sample or due to presence of PCR inhibitors in sample.
. A repeat sample is recommended for confirmation.

ICMR Registration Number: LDSLHRRT


Notes :
1.A negative result in a single upper respiratory sample does not rule out SARS-CoV-2 infection. Hence in such cases a repeat sample after a
gap of 2-4 days after the collection of first specimen for additional testing should be sent. Lower respiratory samples like sputum, BAL, ET
aspirate are more appropriate samples especially in the more severe and progressive lung disease.
2.A detected test result does not differentiate between viable / replicating and non-viable organism.
3.Sensitivity of this test depends upon the quality of sample submitted for testing and stage of infection.
4.Covid- 19 testing done using ICMR/ US-FDA/ CE-IVD approved kits.
5.Test conducted on Nasopharyngeal & Oropharyngeal Swabs.
ClinicalSignificance:
Corona viruses are a large group of viruses that causes illness ranging from the common cold to more severe diseases like Middle East
Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory syndrome (SARS-CoV). Coronavirus (COVID-19 ) is a new strain that was
discovered in 2019 and has been not previously identified in humans. Common signs of infection include respiratory symptoms, fever and
cough, shortness of breath and breathing difficulties. In more severe cases infection can cause pneumonia, severe acute respiratory syndrome
and kidney failure.

Sample Type : Nasopharyngeal swab/Oropharyngeal swab


Please Correlate With Clinical Findings If Necessary Discuss
* This Is an Electronically Authenticated Report *

Dr.RAKHEE
AGARWAL
Consultant Microbiologist

**** END OF REPORT ****

Page 1 of 1

You might also like